Ashley Taylor
Dr Ashley Taylor is a medicinal chemist with expertise in both fragment-based drug discovery and structural biology. He obtained his PhD at Monash University under the supervision of Professor Martin Scanlon working on the development of small molecule inhibitors of Dengue RdRp. Ashley then completed a postdoc at Vanderbilt University (America) with Professor Stephen Fesik focusing on the development of PLPro inhibitors where he served as the lead chemist and crystallographer. This work has led to a patent and several publications. Ashley has recently returned to Monash University where he is focusing on broad spectrum flaviviral protease inhibitors
Abstracts this author is presenting:
